These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

612 related articles for article (PubMed ID: 22051277)

  • 1. Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers.
    Wolf AS; Richards WG; Jaklitsch MT; Gill R; Chirieac LR; Colson YL; Mohiuddin K; Mentzer SJ; Bueno R; Sugarbaker DJ; Swanson SJ
    Ann Thorac Surg; 2011 Nov; 92(5):1819-23; discussion 1824-5. PubMed ID: 22051277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis.
    El-Sherif A; Gooding WE; Santos R; Pettiford B; Ferson PF; Fernando HC; Urda SJ; Luketich JD; Landreneau RJ
    Ann Thorac Surg; 2006 Aug; 82(2):408-15; discussion 415-6. PubMed ID: 16863738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer.
    Okami J; Ito Y; Higashiyama M; Nakayama T; Tokunaga T; Maeda J; Kodama K
    Ann Thorac Surg; 2010 Nov; 90(5):1651-6. PubMed ID: 20971281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sublobar resections in stage IA non-small cell lung cancer: segmentectomies result in significantly better cancer-related survival than wedge resections.
    Sienel W; Dango S; Kirschbaum A; Cucuruz B; Hörth W; Stremmel C; Passlick B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):728-34. PubMed ID: 18261918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer.
    Birdas TJ; Koehler RP; Colonias A; Trombetta M; Maley RH; Landreneau RJ; Keenan RJ
    Ann Thorac Surg; 2006 Feb; 81(2):434-8; discussion 438-9. PubMed ID: 16427827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study.
    Okada M; Koike T; Higashiyama M; Yamato Y; Kodama K; Tsubota N
    J Thorac Cardiovasc Surg; 2006 Oct; 132(4):769-75. PubMed ID: 17000286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublobar resection versus definitive radiation in patients with stage IA non-small cell lung cancer.
    Fernandez FG; Crabtree TD; Liu J; Meyers BF
    Ann Thorac Surg; 2012 Aug; 94(2):354-60; discussion 360-1. PubMed ID: 22429673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublobar versus lobar resection: current status.
    Narsule CK; Ebright MI; Fernando HC
    Cancer J; 2011; 17(1):23-7. PubMed ID: 21263263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does lobectomy achieve better survival and recurrence rates than limited pulmonary resection for T1N0M0 non-small cell lung cancer patients?
    Chamogeorgakis T; Ieromonachos C; Georgiannakis E; Mallios D
    Interact Cardiovasc Thorac Surg; 2009 Mar; 8(3):364-72. PubMed ID: 18641014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer.
    Fernando HC; Santos RS; Benfield JR; Grannis FW; Keenan RJ; Luketich JD; Close JM; Landreneau RJ
    J Thorac Cardiovasc Surg; 2005 Feb; 129(2):261-7. PubMed ID: 15678034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic predictors in non-small cell lung cancer patients undergoing intentional segmentectomy.
    Koike T; Koike T; Yamato Y; Yoshiya K; Toyabe S
    Ann Thorac Surg; 2012 Jun; 93(6):1788-94. PubMed ID: 22560265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ["Intentionally" limited pulmonary resection versus lobectomy for the treatment of peripheral stage IA non-small cell lung cancers].
    Mondello B; Sibilio M; Pavone A; Monaco F; Nunnari F; Micali V; Vasta I; Perrone O; Monaco M
    G Chir; 2007; 28(1-2):7-12. PubMed ID: 17313726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer.
    Zemlyak A; Moore WH; Bilfinger TV
    J Am Coll Surg; 2010 Jul; 211(1):68-72. PubMed ID: 20610251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bronchial resection margin length and clinical outcome in non-small cell lung cancer.
    Tomaszek SC; Kim Y; Cassivi SD; Jensen MR; Shen KH; Nichols FC; Deschamps C; Wigle DA
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1151-6. PubMed ID: 21450488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublobar resection in nonsmall cell lung carcinoma.
    Bilfinger TV; Baram D
    Curr Opin Pulm Med; 2008 Jul; 14(4):292-6. PubMed ID: 18520261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local control of disease related to lymph node involvement in non-small cell lung cancer after sleeve lobectomy compared with pneumonectomy.
    Kim YT; Kang CH; Sung SW; Kim JH
    Ann Thorac Surg; 2005 Apr; 79(4):1153-61; discussion 1153-61. PubMed ID: 15797043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival after lobectomy versus segmentectomy for stage I non-small cell lung cancer: a population-based analysis.
    Whitson BA; Groth SS; Andrade RS; Maddaus MA; Habermann EB; D'Cunha J
    Ann Thorac Surg; 2011 Dec; 92(6):1943-50. PubMed ID: 21962268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factor analysis of locoregional recurrence after sublobar resection in patients with clinical stage IA non-small cell lung cancer.
    Koike T; Koike T; Yoshiya K; Tsuchida M; Toyabe S
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):372-8. PubMed ID: 23870323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.